Home » Newsletters » BioWorld Science

BioWorld Science

April 19, 2005

View Archived Issues

New data on the pharmacokinetics and metabolism of viramidine

Atorvastatin prevents autoimmune disease by interfering with Ras and Rho GTPase prenylation

EGCG exerts neuroprotective and antiinflammatory actions in murine EAE

Monoclonal antibodies prevent hepatitis C viral reinfection

GB Therapeutics changes name to Cita NeuroPharmaceuticals

Therapeutic potential of the histamine H3 receptor antagonist ABT-239

Leinamycin prodrug activated by oxidative stress in prostate tumor cells

Xsira inlicenses adenosine for reduction of postoperative pain

Target selection in Celera Genomics and Abbott collaboration

NDA resubmission for indiplon capsules

FDA ready to review OrCel PMA application

Positive findings in proof-of-principle study for COL-3 in rosacea

Genentech extends support of Curis collaborative efforts

U.K. clearance for phase IIb CoFactor study in metastatic colorectal cancer

2ME2 receives orphan drug designation for ovarian cancer

Phase I study begins dosing for intranasal RSV vaccine

Lundbeck looks back at 2004

First small-molecule agonists of orphan estrogen-related receptors synthesized

PharmaFrontiers updates recent progress

Second year of SBIR funding supports GelVac evaluation

FDA approval of Liberte stent

New treatments for diabetes claimed by Arena

Antiobesity drugs disclosed in patents from Banyu and BMS

Bionaut and AnalytiCon Discovery sign lead optimization agreement for cancer

REP-9: A highly potent broad-spectrum antiviral agent

Selective dual-specificity phosphatase inhibitors with potential as anticancer agents

Novel mechanism of antitumor activity demonstrated for NK-314

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...